Robert Veve
Impact in
-
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lung Cancer Diagnosis and Treatment
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
Papers in
- Oncology 6
- HER2/EGFR in Cancer Research 4
- Cancer Cells and Metastasis 2
-
- Lung Cancer Treatments and Mutations 5
- Lung Cancer Diagnosis and Treatment 1
- Co-authors
- Wilbur A. Franklin (7 shared papers)Fred R. Hirsch (4 shared papers)Paul A. Bunn (5 shared papers)Roy Martin Bremnes (3 shared papers)Anna E. Barón (3 shared papers)Chan Zeng (2 shared papers)Marileila Varella‐Garcia (2 shared papers)Michael V. Di Maria (1 shared paper)
- Journals
- Lung Cancer (2 papers)Journal of Clinical Oncology (2 papers)Seminars in Oncology (2 papers)The American Surgeon (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United StatesNorwaySpain
In The Last Decade
Robert Veve
11 papers receiving 2.4k citations
Robert Veve's Hit Papers
Peers
Comparison fields: 5 of 86
- Pulmonary and Respiratory Medicine 1.2k
- Oncology 739
- Cancer Research 161
- Immunology and Allergy 41
- Otorhinolaryngology 43
Countries citing papers authored by Robert Veve
This map shows the geographic impact of Robert Veve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Veve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Veve more than expected).
Fields of papers citing papers by Robert Veve
This network shows the impact of papers produced by Robert Veve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Veve. The network helps show where Robert Veve may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Veve, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis Hit paper breakdown → | 2003 | 1251 |
| 2 | 2002 | 255 | |
| 3 | 2002 | 254 | |
| 4 | 2002 | 214 | |
| 5 | 2002 | 214 | |
| 6 | 2005 | 113 | |
| 7 | 2002 | 93 | |
| 8 | 2003 | 54 | |
| 9 | 2008 | 11 | |
| 10 | 2000 | 9 | |
| 11 | 2002 | 4 |
About Robert Veve
Robert Veve is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology and Allergy, Neurology and Epidemiology, having authored 11 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), HER2/EGFR in Cancer Research (4 papers), Cancer Cells and Metastasis (2 papers), Lung Cancer Diagnosis and Treatment (1 paper), Urinary and Genital Oncology Studies (1 paper), Autoimmune Neurological Disorders and Treatments (1 paper), Wnt/β-catenin signaling in development and cancer (1 paper) and Cell Adhesion Molecules Research (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.2k citations), Oncology (739 citations), Cancer Research (161 citations), Immunology and Allergy (41 citations) and Otorhinolaryngology (43 citations). Robert Veve has collaborated with scholars based in United States, Norway and Spain. Frequent co-authors include Wilbur A. Franklin, Fred R. Hirsch, Paul A. Bunn, Roy Martin Bremnes, Anna E. Barón, Chan Zeng, Marileila Varella‐Garcia, Michael V. Di Maria, Barbara A. Helfrich and Fred R. Hirsch. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, Seminars in Oncology, The American Surgeon and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.